Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.25p
   
  • Change Today:
    -0.30p
  • 52 Week High: 12.50
  • 52 Week Low: 5.80
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 2,399,822
  • Market Cap: 48.88m
  • Beta: 0.75

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -904.7% -122.6%
ROCE 5574.3%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 10.9 2.5
Pr/Book 9.0  
Latest F'cast
Revenue 194.1% 338.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 11.88 (5.15) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 4.47 (40.08) (17.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 19.57 (23.99) (3.53)p n/a n/a n/a n/a 0.0%
31-Dec-24 64.79 (10.06) (1.07)p n/a n/a n/a n/a 0.0%
31-Dec-25 120.64 16.23 2.34p 2.7 n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Latest STX Director Deals

Traded Action Notifier PriceAmountValue
21-Nov-23 Buy Hans-Peter Hasler 6.10p 2,000,000 122,000.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 6.25p
Change Today -0.30p
% Change -4.58 %
52 Week High 12.50
52 Week Low 5.80
Volume 2,399,822
Shares Issued 782.06m
Market Cap 48.88m
Beta 0.75

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.3% below the market average57.3% below the market average57.3% below the market average57.3% below the market average57.3% below the market average
19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average
Price Trend
44.89% below the market average44.89% below the market average44.89% below the market average44.89% below the market average44.89% below the market average
1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average
Income Not Available
Growth
55.95% above the market average55.95% above the market average55.95% above the market average55.95% above the market average55.95% above the market average
79.49% above the sector average79.49% above the sector average79.49% above the sector average79.49% above the sector average79.49% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
16:03 1,000,000 @ 6.27p
16:36 288,000 @ 2.48p
16:23 150,000 @ 6.30p
15:33 40,000 @ 6.28p
15:19 4,573 @ 6.28p

Top of Page